Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,116,112
+$8,425,998 QoQ
Shares Held
5,375,456
+57.0% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,513,200,662 across 316 Biotechnology names. ALLO ranks #59 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in ALLO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,116,112 | 5,375,456 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,690,114 | 3,423,441 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,195,718 | 3,383,644 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,822,944 | 1,613,225 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,029,644 | 2,075,099 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,776,856 | 2,712,139 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,834,316 | 2,797,970 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,898,368 | 2,960,673 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,543,680 | 1,911,338 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,429,676 | 2,314,541 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,121,700 | 1,300,221 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,705,316 | 1,952,780 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,271,140 | 1,876,749 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,134,775 | 1,611,252 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,996,011 | 832,964 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,813,489 | 159,078 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,692,434 | 954,164 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,831,681 | 189,791 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $817,842 | 31,359 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,796,591 | 192,538 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,673,069 | 343,624 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,750,876 | 364,648 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $10,850,288 | 253,393 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||